GPT and metabolic dysfunction-associated steatotic liver disease: However, some concerns have been raised about that lowering the upper limit of ALT will increase the proportion of people at risk for NAFLD and increase unnecessary medical evaluation and costs (56), similar to the opposing opinions on lowering the thresholds for blood glucose (59) and BP (60) in recent years.